https://scholars.lib.ntu.edu.tw/handle/123456789/617130
Title: | Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial | Authors: | El-Khoueiry A.B. Sangro B. Yau T. Crocenzi T.S. Kudo M. CHIUN HSU Kim T.-Y. Choo S.-P. Trojan J. Welling T.H. 3rd, Meyer T. Kang Y.-K. Yeo W. Chopra A. Anderson J. dela Cruz C. Lang L. Neely J. Tang H. Dastani H.B. Melero I. |
Issue Date: | 2017 | Publisher: | Lancet Publishing Group | Journal Volume: | 389 | Journal Issue: | 10088 | Start page/Pages: | 2492-2502 | Source: | The Lancet | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018660134&doi=10.1016%2fS0140-6736%2817%2931046-2&partnerID=40&md5=e2e26b2258101debb72474536abee580 https://scholars.lib.ntu.edu.tw/handle/123456789/617130 |
ISSN: | 0140-6736 | DOI: | 10.1016/S0140-6736(17)31046-2 |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.